Personalized medicine breakthrough for childhood leukemia
Researchers from Newcastle University and Great Ormond Street Hospital have identified new predictors of relapse in children and young people with acute lymphoblastic leukemia (ALL) treated with the immunotherapy drug blinatumomab, as part of a U.K.-wide study.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.